Skip to main content

Whither Triglycerides in the Cholesterol Campaign

  • Chapter
  • 120 Accesses

Part of the book series: Medical Science Symposia Series ((MSSS,volume 1))

Abstract

Considerable controversy remains about whether triglycerides are an important risk factor for coronary heart disease (CHD). Virtually every data set looking at the univariate relationship of triglycerides to subsequent CHD has shown what we found in Framingham in the 5127, men and women free of cardiovascular disease at entry, followed for 30 years, using in this case measures of the very low density lipoproteins, the principal carrier of triglycerides, determined in an analytical ultracentrifuge as the Sf 20 – 400 lipoproteins by Dr. John Gofman (8) (Figure 1). This figure shows that the men and women with the highest triglycerides run the highest rates of CHD and the men and women with the lowest triglycerides run the lowest rates of CHD. On multivariate analysis this is an independent risk factor in women; it was not an independent risk factor in men after adjusting for HDL cholesterol. Not only are the triglycerides an independent risk factor in women but on likelihood ratio analysis they are a more powerful predictor of CHD in women than are the LDL cholesterols (9). Through the years in the Framingham Heart Study, triglycerides were measured in many ways: non-fasting, spun in the preparative ultracentifuge for one hour to remove chylomicrons, non-fasting, fasting for 12 to 14 hours.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Austin MA, Hreslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. (1988):JAMA, 260: 1917–1921.

    Article  PubMed  CAS  Google Scholar 

  2. Austin MA, King M-C, Vranizan KM, Krauss RM. (1990):Circulation,82:495–506.

    Article  PubMed  CAS  Google Scholar 

  3. Brewster DW, Bombick DW, Matsumura F. (1988):J Toxicology & Environ Health,25:495–507.

    Article  CAS  Google Scholar 

  4. Carlson LA, Rosenhamer G. (l988):Acta Med Scand.,223: 405–418.

    Article  Google Scholar 

  5. Castelli W. (l988):Canad. J. of Cardiol.,4:Suppl A:5A–10A.

    Google Scholar 

  6. Dean JD, Jones CJH, Hutchison SJ, Peters JR, Henderson AH. (1991):Lancet,i:456–457.

    Google Scholar 

  7. Frick MH, Elo O, Haapa K, et al. (1987):N Engl J Med.,317:1237–1245.

    Article  PubMed  CAS  Google Scholar 

  8. Gofman JW. (1956):Circulation,14:691–741.

    Article  CAS  Google Scholar 

  9. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. (1977):Am J Med.,62:707–714.

    Article  PubMed  CAS  Google Scholar 

  10. Grundy SM, Mok HY, Zech L, et al. (1979):J. Clin Invest.,63: 1274–1283.

    Article  PubMed  CAS  Google Scholar 

  11. Kaplan N. (l989):Arch Int Med.,149:1514–1520.

    Article  Google Scholar 

  12. Kissebah AH, Vydelingum N, Murray R, et al., (1982): J Clin Endocrinol Metabol.54:254–260.

    Article  CAS  Google Scholar 

  13. Krauss RM, Burke DJ. (1982):J Lipid Res.,23:97–104.

    PubMed  CAS  Google Scholar 

  14. Lovati MR, Galbussera M, Franceschini G, Weber G, Resi L, Tanganelli P, Sirtori CR. (1984):Toxicology and Appl Pharm.,75:91–97.

    Article  CAS  Google Scholar 

  15. Packard CJ, Munro A, Lorimer AR, Gotto AM, Shephard J. (1984):J Clin Invest.,74:2178–2192.

    Article  PubMed  CAS  Google Scholar 

  16. Poapst M, Reardon M, Steiner G. (1985):Arteriosclerosis,5:381–390.

    Article  PubMed  CAS  Google Scholar 

  17. Reaven GM. (1988):Diabetes,37:1595–1607.

    Article  PubMed  CAS  Google Scholar 

  18. Sacks FM, Breslow JL. (1987):Arteriosclerosis,7:35–46.

    Article  PubMed  CAS  Google Scholar 

  19. Schonfeld G, Weidman SW, Witztum JL, Bowen RM. (1976): Metabolism: Clinical & Experimental,25:261–275.

    Article  CAS  Google Scholar 

  20. Sniderman A, Wolfson C, Teng B, Franklin FA, Barchorik P, Kwiterovitch PO. (1982):Ann Intern Med.,97:833–839.

    Article  PubMed  CAS  Google Scholar 

  21. Williams RR, Hunt SC, Hopkins PN, et al. (1988):JAMA.259:3579–3586.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Castelli, W.P. (1992). Whither Triglycerides in the Cholesterol Campaign. In: Gotto, A.M., Lenfant, C., Paoletti, R., Soma, M. (eds) Multiple Risk Factors in Cardiovascular Disease. Medical Science Symposia Series, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2700-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-2700-4_29

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5196-5

  • Online ISBN: 978-94-011-2700-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics